603567.SS · 珍宝岛
China A-shares · RS rating 32 · As of 2026-10-14
| Price | 5.21 CNY |
|---|---|
| 1-day change | -0.8% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 45 / 80 / 4 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 20 / 20 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -37.3% |
| Distance from 52-week high | +56.9% |
| Market cap (USD) | $739.6M |